AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact News To Know: PATH and Jhpiego just launched a call for Expression of Interest (EOI) to identify potential industry partners that can contribute to improving access to life-saving medicines in low- and middle-income countries to prevent and treat postpartum hemorrhage. Manufacturers of misoprostol tablets and tranexamic acid injectables are encouraged to apply! Did you know? Postpartum hemorrhage
August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum
Don’t take our word for it – let Trevor Noah tell you about us. Thank you to Trevor and our friends at The Daily Show for including us in this entire week’s series of shows! Check out Trevor’s spotlight on Jhpiego’s work guaranteeing healthier futures for women and families globally.
